Loading Events

« All Events

  • This event has passed.

ADOPT 2016

02/03/2016 - 03/03/2016

HW_ADOPT logo

ADOPT 2016 will give you access to the very latest clinical implement best practice to enhance genetic engineering of cells. Whether adopting an allogeneic or autologous model, define your bioprocessing and logistics needs to ensure global commercial viability of your adoptive cell immunotherapy pipeline. Scientific and business leaders from pharma, biotech, academia and the wider service community will come together to forge a roadmap for emerging genetically engineered cell immunotherapies.

Expert speakers include:

  • Cedrik Britten, Head Cellular Therapy, Immuno-oncology, GSK
  • Arnaud Foussat, CSO, TxCell
  • Dvorit Samid, SVP, Medical Affairs, NantKwest
  • Helen Tayton-Martin, COO, AdaptImmune
  • Vidal de la Cruz, VP, Preclinical R&D, Formula Pharmaceuticals

For more information and to register, click here

Details

Start:
02/03/2016
End:
03/03/2016
Event Category:
Website:
http://adoptive-immunotherapies.com/

Venue

Kensington Close Hotel
Wrights Lane
London, W8 5SP United Kingdom
+ Google Map

We use cookies to give you the best experience and for advertising purposes. By accepting, you support our independent media and it's freely accessible content.